Daniel Burkhoff and Akshay Desai discuss the innovative technologies and late-breaking science presented at day 2 of THT.
The findings suggest clinicians don’t need to be as aggressive in lowering BP in this population, at least early after ...
Amid late-breaking coronary, structural, and endovascular trials will be a keynote from President Biden, and more.
Patients already had high NT-proBNP levels at baseline, though, raising questions about the quality of GDMT, Nancy Sweitzer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results